Global Peptide Synthesis Market Size will Reach $719.38 Million in 2023

Global Peptide Synthesis Market Overview

According to Global Market Monitor, the global peptide synthesis market size will reach $719.38 million in 2023 with a CAGR of 7.17% from 2023 to 2028.

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups is commonly necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide and thus progresses toward the amino-terminus. This is the opposite direction of protein biosynthesis.

Peptide Synthesis Industry Participants Increases.

The growing involvement of public and private institutions in synthetic biology research is contributing to the growth of the market. The growing involvement of research entities has led to an increase in overall research and development (R&D) investment and advanced biology-based products to overcome global health challenges, including increased incidence of chronic diseases. Technological innovations have an important role in driving the growth of the market. To sustain in the competitive market, vendors should develop new ideas and technologies and stay up-to-date with the advanced technologies.

Market Dynamics

The research and development of peptide therapies are increasing, as they are cost-effective, efficient, and have lower toxicity. The major factor driving the market for peptide synthesis in pharmaceutical and biotechnology companies is rapid technological advancements in peptide synthesizers and a strong peptide therapeutics pipeline. For instance, the article published in Science Direct in 2022 under the title 'Advances in oral peptide drug nanoparticles for diabetes mellitus treatment' stated that a promising approach to treating diabetes mellitus is through oral administration of peptide medications. In comparison to parenteral administration methods, oral administration of peptide medicines is found to be a potential approach for the treatment of diabetes mellitus due to its ease and high patient compliance.

North America dominates the overall peptide synthesis market. The dominance is due to the growing prevalence of obesity with a rise in sedentary deskbound lifestyles, and lack of proper diet and physical activity resulting in various chronic diseases like diabetes. The high prevalence of diabetes is expected to continue resulting in higher demand for peptide therapeutics driving the market. In 2022, the United States Food and Drug Administration approved Mounjaro (tripeptide) injection to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise. 

By Type	Under 75%
	75% to 85%
	Above 85%
By Application	Commercial
	Academic Research
By Region	North America
	Asia-Pacific
	Europe
	Central & South America
	Middle East & Africa
	North America dominates the overall peptide synthesis market.